glp 1 agonists and sglt2 inhibitors SGLT-2 GLP-1 Agonists: First-Line Therapy for Diabetes With Established Cardiovascular Disease Type 2 Diabetes: The Effects
Description
For women in perimenopause and menopause, dosing decisions should follow a structured evaluation
Systematic Reviews and Meta-analyses One collaborative meta-analysis that synthesized the cardiovascular outcomes reported the results from four studies and 45,568 patients on the add-on therapy modalities [20]
[DOI] [PMC free article] [PubMed] [Google Scholar] 63.Klausen M.K., Jensen M.E., Moller M., et al
2 Department of Pharmaceutical Sciences, State University of New York, Buffalo, NY, 14214, USA
Intestinal L cells-derived GLP-1 induce insulin secretion in response to meal intake
